(1)
Ligand-Based Drug Design Studies of Different Flavonoids As a Potential Inhibitor of BCR-ABL. UCP J. Sci. Technol. 2025, 3 (1), 29-45. https://doi.org/10.24312/ucp-jst.03.01.704.